Clinical Trial Update: Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating a modified triple-doublet therapy in women with newly diagnosed Mullerian carcinomas (ovarian, fallopian tube, or primary peritoneal c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: COMPLETED